Tezacaftor-ivacaftor is safe and efficacious in patients with cystic fibrosis with Phe508del mutations

Lancet Respir Med. 2018 Jan;6(1):13-14. doi: 10.1016/S2213-2600(17)30439-3. Epub 2017 Dec 14.
No abstract available

Publication types

  • Comment

MeSH terms

  • Aminophenols
  • Benzodioxoles
  • Cystic Fibrosis*
  • Heterozygote
  • Humans
  • Indoles
  • Mutation
  • Quinolones

Substances

  • Aminophenols
  • Benzodioxoles
  • Indoles
  • Quinolones
  • tezacaftor
  • ivacaftor